No abstract available
MeSH terms
-
Anaplastic Lymphoma Kinase
-
Antibodies, Monoclonal, Murine-Derived / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bleomycin / therapeutic use
-
Cyclophosphamide / therapeutic use
-
Dacarbazine / therapeutic use
-
Doxorubicin / therapeutic use
-
Hodgkin Disease / drug therapy
-
Humans
-
Lymphoma / classification
-
Lymphoma / drug therapy*
-
Lymphoma / pathology*
-
Lymphoma, Large B-Cell, Diffuse / drug therapy
-
Lymphoma, Large-Cell, Anaplastic / drug therapy
-
Lymphoma, Large-Cell, Anaplastic / metabolism
-
Lymphoma, Non-Hodgkin / drug therapy
-
Prednisone / therapeutic use
-
Receptor Protein-Tyrosine Kinases / metabolism
-
Rituximab
-
Vinblastine / therapeutic use
-
Vincristine / therapeutic use
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents
-
Bleomycin
-
Rituximab
-
Vincristine
-
Vinblastine
-
Dacarbazine
-
Doxorubicin
-
Cyclophosphamide
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases
-
Prednisone
Supplementary concepts
-
ABVD protocol
-
CHOP protocol